Tue, May 21, 2013, 5:08 PM EDT - U.S. Markets closed
The buyout says it all.
INCY's stock price is merely confirmation.
On the basis that GILD bought YMI instead of INCY? Nonsense.
Nobody wants INCY. As for YMI, the buyout says it all.
The GILD drug may not even be approvable. But even if it is, Incyte will sell $half a billion worth of Jakafi before they see competition.
Jacosa, you're one of only a few who even make any sense on this board. The rest are merely for entertainment purposes only!! Keep up the great insight!!
Clearly. So in that case be gone.